AVDL vs. CLF

Last updated Jun 9, 2026

AVDL (Avadel Pharmaceuticals plc) and CLF (Cleveland-Cliffs Inc.) are both stocks. AVDL operates in Drug Manufacturers - Specialty & Generic (Healthcare), while CLF operates in Steel (Basic Materials). At a 0.13 correlation, their price movements are largely independent.

Performance

AVDL vs. CLF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avadel Pharmaceuticals plc (AVDL) and Cleveland-Cliffs Inc. (CLF). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

AVDL

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CLF

• 1D: -6.28%
• 1M: 15.06%
• YTD: -4.52%
• 6M: 2.51%
• 1Y: 66.84%
• 3Y*: -7.46%
• 5Y*: -11.40%
• 10Y*: 10.01%

*Multi-year figures are annualized to reflect compound growth (CAGR)

AVDL vs. CLF - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
AVDL Avadel Pharmaceuticals plc	0.42%	105.04%	-25.57%	97.21%	-11.39%	20.96%	-11.52%	192.64%	-68.54%	-21.08%
CLF Cleveland-Cliffs Inc.	-4.52%	41.28%	-53.97%	26.75%	-26.00%	49.52%	77.38%	12.72%	6.66%	-14.27%

Correlation

The correlation between AVDL and CLF is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.07
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (5Y) Calculated over the trailing 5-year period	0.14
Correlation (10Y) Calculated over the trailing 10-year period	0.12
Correlation (All Time) Calculated using the full available price history since Jun 7, 1996	0.13

Fundamentals

Market Cap AVDL : $2.19B CLF : $7.16B
EPS AVDL : -$0.00 CLF : -$2.37
PS Ratio AVDL : 8.72 CLF : 0.34
PB Ratio AVDL : 22.31 CLF : 1.23
Total Revenue (TTM) AVDL : $248.52M CLF : $18.90B
Gross Profit (TTM) AVDL : $234.76M CLF : -$528.00M
EBITDA (TTM) AVDL : $10.13M CLF : $134.00M

Return for Risk

AVDL vs. CLF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLF

CLF Risk / Return Rank: 68
CLF Sharpe Ratio Rank: 72
CLF Sortino Ratio Rank: 69
CLF Omega Ratio Rank: 68
CLF Calmar Ratio Rank: 67
CLF Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVDL vs. CLF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avadel Pharmaceuticals plc (AVDL) and Cleveland-Cliffs Inc. (CLF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	AVDL	CLF	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.98	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.19	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.16	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.13	—

Drawdowns

Drawdown Indicators

	AVDL	CLF	Difference
Max Drawdown Largest peak-to-trough decline	—	-98.78%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-51.67%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-74.46%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-82.37%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-82.37%	—
Current Drawdown Current decline from peak	—	-87.07%	—
Average Drawdown Average peak-to-trough decline	—	-47.61%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	25.01%	—

Volatility

Volatility by Period

	AVDL	CLF	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	20.72%	—
Volatility (6M) Calculated over the trailing 6-month period	—	46.41%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	68.41%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	59.53%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	62.05%	—

Dividends

AVDL vs. CLF - Dividend Comparison

Neither AVDL nor CLF has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
AVDL Avadel Pharmaceuticals plc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
CLF Cleveland-Cliffs Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.82%	3.10%

Financials

Frequently Asked Questions

Can I hold both AVDL and CLF in my portfolio?

AVDL and CLF have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.